Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanguy Chaumette

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Biochemical and Biophysical Research Communications|March 24, 2009
Neuroplasticity and neuroprotection in enteric neurons: role of epithelial cellsRaphaël Moriez, Hind Abdo, Tanguy Chaumette, et al.
The European Journal of Neuroscience|August 29, 2009
The second brain and Parkinson's diseaseThibaud Lebouvier, Tanguy Chaumette, Sébastien Paillusson, et al.
Infection and Immunity|September 15, 2020
Pseudomonas aeruginosa Infection Impairs NKG2D-Dependent NK Cell Cytotoxicity through Regulatory T-Cell ActivationMickael Vourc'h, Gaelle David, Benjamin Gaborit, et al.
Oncoimmunology|June 5, 2013
Inhibition of tumor angiogenesis by globotriaosylceramide immunotargetingStéphane Birklé, Ariane Desselle, Tanguy Chaumette, et al.
The Journal of Infectious Diseases|May 21, 2021
Circulating Regulatory T Cells Expressing Tumor Necrosis Factor Receptor Type 2 Contribute to Sepsis-Induced Immunosuppression in Patients During Septic ShockBenjamin Jean Gaborit, Tanguy Chaumette, Marie Chauveau, et al.
Plos One|November 29, 2012
Anti-Gb3 monoclonal antibody inhibits angiogenesis and tumor developmentAriane Desselle, Tanguy Chaumette, Marie-Hélène Gaugler, et al.
Plos One|February 13, 2014
Chimeric antibody c.8B6 to O-acetyl-GD2 mediates the same efficient anti-neuroblastoma effects as therapeutic ch14.18 antibody to GD2 without antibody induced allodyniaMickaël Terme, Mylène Dorvillius, Denis Cochonneau, et al.
Pain|January 25, 2020
c-Jun/p38MAPK/ASIC3 pathways specifically activated by nerve growth factor through TrkA are crucial for mechanical allodynia developmentTanguy Chaumette, Lauriane Delay, Julie Barbier, et al.
Plos One|October 4, 2011
A monoclonal antibody to O-acetyl-GD2 ganglioside and not to GD2 shows potent anti-tumor activity without peripheral nervous system cross-reactivityNidia Alvarez-Rueda, Ariane Desselle, Denis Cochonneau, et al.
Plos One|September 22, 2010
Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptomsThibaud Lebouvier, Michel Neunlist, Stanislas Bruley des Varannes, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Biochemical and Biophysical Research Communications|March 24, 2009
Neuroplasticity and neuroprotection in enteric neurons: role of epithelial cellsRaphaël Moriez, Hind Abdo, Tanguy Chaumette, et al.
The European Journal of Neuroscience|August 29, 2009
The second brain and Parkinson's diseaseThibaud Lebouvier, Tanguy Chaumette, Sébastien Paillusson, et al.
Infection and Immunity|September 15, 2020
Pseudomonas aeruginosa Infection Impairs NKG2D-Dependent NK Cell Cytotoxicity through Regulatory T-Cell ActivationMickael Vourc'h, Gaelle David, Benjamin Gaborit, et al.
Oncoimmunology|June 5, 2013
Inhibition of tumor angiogenesis by globotriaosylceramide immunotargetingStéphane Birklé, Ariane Desselle, Tanguy Chaumette, et al.
The Journal of Infectious Diseases|May 21, 2021
Circulating Regulatory T Cells Expressing Tumor Necrosis Factor Receptor Type 2 Contribute to Sepsis-Induced Immunosuppression in Patients During Septic ShockBenjamin Jean Gaborit, Tanguy Chaumette, Marie Chauveau, et al.
Plos One|November 29, 2012
Anti-Gb3 monoclonal antibody inhibits angiogenesis and tumor developmentAriane Desselle, Tanguy Chaumette, Marie-Hélène Gaugler, et al.
Plos One|February 13, 2014
Chimeric antibody c.8B6 to O-acetyl-GD2 mediates the same efficient anti-neuroblastoma effects as therapeutic ch14.18 antibody to GD2 without antibody induced allodyniaMickaël Terme, Mylène Dorvillius, Denis Cochonneau, et al.
Pain|January 25, 2020
c-Jun/p38MAPK/ASIC3 pathways specifically activated by nerve growth factor through TrkA are crucial for mechanical allodynia developmentTanguy Chaumette, Lauriane Delay, Julie Barbier, et al.
Plos One|October 4, 2011
A monoclonal antibody to O-acetyl-GD2 ganglioside and not to GD2 shows potent anti-tumor activity without peripheral nervous system cross-reactivityNidia Alvarez-Rueda, Ariane Desselle, Denis Cochonneau, et al.
Plos One|September 22, 2010
Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptomsThibaud Lebouvier, Michel Neunlist, Stanislas Bruley des Varannes, et al.
Pageof 2